Clinical trial
Study of a Bupivacaine Patch (Eladur™) to Treat Post- Herpetic Neuralgia
NCT00478179 · Durect, Industry · Completed
Key facts
| NCT number | NCT00478179 |
|---|---|
| Title | Study of a Bupivacaine Patch (Eladur™) to Treat Post- Herpetic Neuralgia |
| Official title | A Randomized, Double-Blind, Placebo Controlled, Two-Way Cross-Over Study of Analgesic Efficacy of Bupivacaine Transdermal Therapeutic System in Patients With Post-Herpetic Neuralgia |
| Lead sponsor | Durect, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Postherpetic Neuralgia, Pain |
| Intervention type | Drug |
| Interventions | Transdermal/Patch (Bupivacaine TTS [Eladur™]) |
| Enrollment | 60 |
| Start date | Sep 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | May 24, 2007 |
| Last update posted | Sep 11, 2009 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: